CCR5 and HIV infectious disease: In HIV infection, low levels of soluble RAGE have been found in infected subjects with subclinical carotid atherosclerosis under ART [104], but also complex protective effects against cys-infection from myeloid dendritic cells due to CCR5 repression, in spite of the induction of proinflammatory cytokines [105].